Verastem, Inc. (VSTM) Stock Forecast
VSTM analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.90 / 5 from 10 analysts
- Price target
- $17.22 average of analyst targets
- Upside to target
- +99.1% from the latest close
- Next earnings
- November 3, 2026 EPS estimate $-0.44
- 52-week range
- $3.45 – $10.64
VSTM analyst ratings
10 analystsNumber of analysts at each rating.
VSTM price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VSTM earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.44 | −$0.44 | −$0.44 | −$0.54 | +18.5% | 2 |
| Current fiscal year (2026) | −$1.80 | −$1.80 | −$1.80 | −$2.35 | +23.4% | 1 |
| Next fiscal year (2027) | −$1.22 | −$1.22 | −$1.22 | −$1.80 | +32.2% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VSTM revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $26.1M | $24.0M | $30.0M | +132.0% | 9 |
| Current fiscal year (2026) | $111.3M | $94.4M | $125.3M | +260.0% | 9 |
| Next fiscal year (2027) | $159.2M | $134.2M | $188.2M | +43.0% | 8 |
VSTM EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VSTM revenue: reported and forecast
VSTM EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.37 | −$0.43 | −$0.43 | −$0.43 | −$0.44 | +17.9% | 0 up · 1 down |
| Current fiscal year (2026) | −$1.56 | −$1.80 | −$1.80 | −$1.80 | −$1.80 | +15.6% | 1 up · 0 down |
| Next fiscal year (2027) | −$1.16 | −$0.75 | −$0.75 | −$0.75 | −$1.22 | +5.2% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VSTM earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VSTM beat in 8 of 12.
What analysts expect from VSTM
10 analysts cover Verastem; their consensus rating is strong buy (4.90 on a 1–5 scale, where 5 is a strong buy). The average price target is $17.22, 99.1% above the latest close of $8.65. Analysts expect earnings of −$1.80 per share for 2026, +23.4% from a year earlier. For 2027 the average estimate is −$1.22 per share on revenue of $159.2 million. Verastem beat the EPS estimate in 8 of the last 12 quarters.
Related: VSTM income statement, VSTM key metrics, VSTM chart. See the VSTM stock overview for the latest quote and news.
VSTM forecast FAQ
What is Verastem's price target?
The average analyst price target for Verastem is $17.22, 99.1% above the latest close of $8.65.
Is Verastem a buy, hold or sell?
Of 10 analysts covering Verastem, 9 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Verastem's EPS forecast?
Analysts forecast −$1.80 per share for 2026 (range −$1.80 to −$1.80); for 2027 the estimate is −$1.22.
What is Verastem's revenue forecast?
The average revenue estimate for 2026 is $111.3 million, growth of 260.0%; for 2027 it is $159.2 million.
When does Verastem report earnings?
Verastem is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes; the EPS estimate is $-0.44.
Does Verastem usually beat earnings estimates?
Verastem reported EPS at or above the analyst estimate in 8 of the last 12 quarters.